NewsBytes
    Hindi Tamil Telugu
    More
    In the news
    Narendra Modi
    Amit Shah
    Box Office Collection
    Bharatiya Janata Party (BJP)
    OTT releases
    Hindi Tamil Telugu
    NewsBytes
    User Placeholder

    Hi,

    Logout


    India Business World Politics Sports Technology Entertainment Auto Lifestyle Inspirational Career Bengaluru Delhi Mumbai Visual Stories Find Cricket Statistics Phones Reviews Fitness Bands Reviews Speakers Reviews

    Download Android App

    Follow us on
    • Facebook
    • Twitter
    • Linkedin
     
    Home / News / Technology News / COVID-19 vaccine: What are the latest updates?
    COVID-19 vaccine: What are the latest updates?
    Technology

    COVID-19 vaccine: What are the latest updates?

    Written by Shubham Sharma
    June 07, 2020 | 06:42 pm 3 min read
    COVID-19 vaccine: What are the latest updates?

    With a sporadic increase in the number of cases and deaths, COVID-19 is growing beyond control in India. The situation is so grim that people are not even getting hospital beds in the nation's capital. Now, at a time like this, the only way to exit this pandemic is to create and distribute a vaccine. Here are all the developments related to vaccine development.

    AstraZeneca and Oxford moving to mass-produce 2 billion doses

    AZD1222, the COVID-19 vaccine jointly developed by British pharmaceutical giant AstraZeneca and Oxford University has gone into production in partnership with the Serum Institute of India and two Bill Gates-backed global health organizations. The company hopes to have 2 billion doses of the vaccine ready by September so that once clinical trial results are out (expected by August), they could begin distribution immediately.

    US: 2 million doses 'ready-to-go', 200 million by 2021

    American companies are also moving forward with vaccine development. President Donald Trump recently said the country has 2 million doses (possibly the one by Moderna, which is in Phase-2 of clinical trials) ready to go if it checks out for safety. Meanwhile, Director of US's NIAID, Dr. Anthony Fauci, also gave an optimistic timeline, saying they expect to have 200 million doses by 2021.

    University of Queensland producing 100 million doses

    Along with Britain and America, Australia's University of Queensland and biotech company CSL are working to produce 100 million doses of a COVID-19 vaccine that uses an innovative "molecular clamp technology" by the end of next year. Their formula has shown positive results in lab trials and will be tested on some 120 individuals next month before expanding to more people later this year.

    Japan and Singapore also racing to get vaccines ready

    Japan and Singapore have also joined the COVID-19 vaccine race, with the former hoping to have a vaccine developed, mass-produced, and distributed in the first half of 2021. Meanwhile, Singapore claims to be carrying out trials of a vaccine and is moving to ramp up manufacturing for its own mass-production as well as to offer contract-manufacturing services to other vaccine developers.

    133 vaccines developed, 10 going through clinical human trials

    Overall, 133 COVID-19 vaccines have been developed so far. Out of these, 123 are in the pre-clinical trial phase while the remaining 10 are moving through human trials and simultaneous manufacturing (in some cases). The 10 promising candidates come from Moderna, AstraZeneca, CanSino Biological, Novavax, BioNTech, Sinovac, Inovio Pharma, Wuhan Institute of Biological Products, Beijing Institute of Biological Products, and Institute of Medical Biology.

    Share this timeline
    Facebook
    Whatsapp
    Twitter
    Linkedin
    Related News
    Oxford
    Oxford University
    United States of America
    Serum Institute of India
    AstraZeneca

    Oxford

    #COVID19: 5 promising vaccine candidates currently in trial Vaccine
    India will start COVID-19 vaccine production next month: Details here Oxford University
    COVID-19 vaccine efforts are disjointed, says leading medical journal editor Oxford University
    Oxford University's COVID-19 vaccine goes into human trials this week Oxford University

    Oxford University

    New COVID-19 vaccine goes into human trials: Details here Vaccine
    Oxford's COVID-19 vaccine fails key animal trial: Details here Technology
    Moderna's COVID-19 vaccine gets FDA nod for phase 2 trial COVID-19
    China successfully conducts first COVID-19 vaccine trial (on monkeys) COVID-19

    United States of America

    Pakistan: Blogger Cynthia Ritchie accuses ex-Minister Rehman Malik of rape Pakistan News
    Motorola's affordable Moto G Fast, Moto E (2020) go official Motorola
    Reddit co-founder Alexis Ohanian quits board, wants a black replacement Reddit
    Kawasaki recalls over 1,500 units of Ninja ZX-10R Kawasaki

    Serum Institute of India

    Amid coronavirus crisis, this Indian business tycoon is growing richer Mukesh Ambani
    Serum CEO Poonawalla hopes to launch second vaccine by September Adar Poonawalla
    Covishield 90% effective if doses given 2-3 months apart: Poonawalla Vaccine
    AstraZeneca serves legal notice to Serum Institute over vaccine delays Adar Poonawalla

    AstraZeneca

    Awaiting COVID-19 vaccine arrival, Delhi hospital working on storage facility India
    Oxford/AstraZeneca vaccine should be effective against new variant: Report Oxford University
    After Pfizer, Oxford-AstraZeneca's COVID-19 vaccine approved in UK Oxford University
    UK's approval to Oxford-AstraZeneca vaccine paves way for India India
    Next News Article

    Love Technology News?

    Subscribe to stay updated.

    Science Thumbnail
    Indian Premier League (IPL) Celebrity Hollywood Bollywood UEFA Champions League Tennis Football Smartphones Cryptocurrency Upcoming Movies Premier League Cricket News Latest automobiles Latest Cars Upcoming Cars Latest Bikes Upcoming Tablets
    About Us Privacy Policy Terms & Conditions Contact Us Ethical Conduct Grievance Redressal News News Archive Topics Archive Download DevBytes Find Cricket Statistics
    Follow us on
    Facebook Twitter Linkedin
    All rights reserved © NewsBytes 2023